000272968 001__ 272968
000272968 005__ 20250820095711.0
000272968 0247_ $$2doi$$a10.5281/ZENODO.14017635
000272968 0247_ $$2doi$$a10.5281/zenodo.14017635
000272968 0247_ $$2doi$$a10.5281/zenodo.14017634
000272968 037__ $$aDZNE-2024-01347
000272968 1001_ $$0P:(DE-2719)9001592$$aLa Vitola, Pietro$$b0$$eData Collector$$udzne
000272968 245__ $$aDataset: Mitochondrial oxidant stress promotes alpha-synuclein aggregation and spreading in mice with mutated glucocerebrosidase, v1
000272968 260__ $$bZenodo$$c2024
000272968 3367_ $$2BibTeX$$aMISC
000272968 3367_ $$0PUB:(DE-HGF)32$$2PUB:(DE-HGF)$$aDataset$$bdataset$$mdataset$$s1732805601_2419
000272968 3367_ $$026$$2EndNote$$aChart or Table
000272968 3367_ $$2DataCite$$aDataset
000272968 3367_ $$2ORCID$$aDATA_SET
000272968 3367_ $$2DINI$$aResearchData
000272968 520__ $$aThese are the data sets and plasmid sequences of the viral vectors used in the study 'Mitochondrial oxidant stress promotes alpha-synuclein aggregation and spreading in mice with mutated glucocerebrosidase'
000272968 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000272968 588__ $$aDataset connected to DataCite
000272968 7001_ $$0P:(DE-2719)9002553$$aSzegoe, Eva$$b1$$eData Collector$$udzne
000272968 7001_ $$0P:(DE-2719)2772760$$aUlusoy, Ayse$$b2$$eData Collector
000272968 7001_ $$0P:(DE-2719)9001609$$aPinto-Costa, Rita$$b3$$udzne
000272968 7001_ $$0P:(DE-2719)2812656$$aRollar, Angela$$b4$$udzne
000272968 7001_ $$0P:(DE-2719)9001593$$aHarbachova, Eugenia$$b5$$udzne
000272968 7001_ $$0P:(DE-HGF)0$$aSchapira, Anthony HV$$b6
000272968 7001_ $$0P:(DE-2719)2481741$$aDi Monte, Donato A$$b7$$udzne
000272968 773__ $$a10.5281/zenodo.14017635
000272968 909CO $$ooai:pub.dzne.de:272968$$pVDB
000272968 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001592$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000272968 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002553$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000272968 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2772760$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000272968 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001609$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000272968 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812656$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000272968 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001593$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000272968 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2481741$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000272968 9141_ $$y2024
000272968 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000272968 9201_ $$0I:(DE-2719)1013008$$kAG Di Monte$$lNeurodegeneration and Neuroprotection in Parkinson´s Disease$$x0
000272968 980__ $$adataset
000272968 980__ $$aVDB
000272968 980__ $$aI:(DE-2719)1013008
000272968 980__ $$aUNRESTRICTED